Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.
Press releases published on June 19, 2025

Amerigo Scientific Introduces PerKits™ Kits for Precision Drug Conjugation
Amerigo Scientific offers PerKits™ drug conjugation kits to simplify and optimize the conjugation of small-molecule drugs to biomolecules. NEW YORK, NY, UNITED STATES, June 19, 2025 /EINPresswire.com/ -- In the dynamic field of pharma-biomedical, …

Overnight Zoom Karaoke Marathon to Support Suicide Prevention, June 20
Good Karma Karaoke to Host Overnight Zoom Karaoke Marathon in Solidarity with Suicide Prevention Efforts NEW YORK, NY, UNITED STATES, June 19, 2025 /EINPresswire.com/ -- In a powerful show of unity and support for mental health awareness, Good Karma …

Mega Sardines Named World’s First Seafood “Superfood” by MWA
MANILA, Philippines, June 19, 2025 (GLOBE NEWSWIRE) -- Mega Sardines, a flagship brand of Mega Prime Foods Inc., has officially been recognized by the U.S.-based Medical Wellness Association (MWA) as the world’s first seafood Superfood, marking a historic …

CancerVax Nanoparticle Successfully Targets Cancer Cells While Sparing Non-cancerous Cells
Lehi, June 19, 2025 (GLOBE NEWSWIRE) -- Lehi, Utah – June 19, 2025 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform designed to use the body’s immune system to treat cancer, today announced that its ligand conjugated …

HLTH Inc. Unveils HLTH.rad — A Bold New Global Gathering for Imaging Innovators Co-Located with HLTH Europe 2026 in Amsterdam
AMSTERDAM, Netherlands, June 19, 2025 (GLOBE NEWSWIRE) -- HLTH Inc., the leading global platform for health innovation, is proud to announce the launch of HLTH.rad, a groundbreaking new event that will redefine the future of medical imaging, diagnostics, …

Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update
Strong cash position of CHF2.8 million at end of Q1 2025 GABAB PAM chronic cough candidate demonstrated robust anti-tussive activity in disease models Regained rights to our phase 2 mGlu2 PAM asset, ADX71149 Indivior advanced GABAB PAM Substance use …